GLOBAL DIGITAL GENOME MARKET FORECAST 2021-2028

The global digital genome market is anticipated to register a CAGR of 9.43% between 2021 and 2028, and generate revenue of $20606.9 million by 2028.   

The digital genome is a comprehensive digital set of genetic material occurring in an organism or a cell. It acts as a supporter that allows immediate access to trait combinations to solve endless custom queries.

digital-genome-market-growth

Key factors propelling the global digital genome market growth are:

  • Increasing funding by the manufacturers and governments in genomics
  • Advancements in technology
  • Surging prevalence of chronic diseases
    • A majority of older adults (>60%) suffer from two or more chronic conditions.
    • It has recently become possible to measure individual-level risks for these chronic diseases using molecular genetic data from genome-wide association studies (GWAS), which is anticipated to drive the market growth.

Major growth restraining factors:

  • Risks associated with security issue of digital genome
    • There are many risks associated with the security and confidentiality of patient data. The patient data can be misused, which is likely to restrain the market growth.
  • Lack of professionals with adequate knowledge about the genomic technology

The report scope of the global digital genome market includes the segmentation analysis of product, application, and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Diagnostics
    • Diagnostics is the dominating application in the global digital genome market.
    • Genomic technologies can be used to diagnose people with high-risk genetic errors leading to rare diseases. They are increasingly used to analyze rare and common genetic factors influencing the development of common diseases, such as high blood pressure, diabetes, and cancer.
  • Drug Discovery
  • Academic Research
  • Personalized Medicine
    • Personalized medicine is the fastest-growing application in the global digital genome market.
    • Personalized genomic medicine is evaluated to be at the front for improving the prescribing of drug treatments to meet the challenge of delivering a more proficient modern healthcare system, especially for those patients suffering from multi-morbidities.
  • Agricultural
  • Other Applications

Geographically, the global digital genome market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is the dominating region in the global market.
    • The high adoption rate of advanced technology, the presence of major players, and the availability of funds for genomic research, are attributed to the leading market share. Global DNA sequencing giants, such as Thermo Fisher Scientific, Illumina, and others, have their business presence in the United States, thereby boosting the market growth.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global digital genome market are:

  • Biomerieux SA
  • Hoffmann-la Roche
  • PerkinElmer Inc
  • Qiagen NV
  • Others

Key strategies adopted by some of the digital genome companies:

In January 2021, Illumina Inc announced new oncology partnerships with Kura Oncology, Bristol Myers Squibb, Merck, and Myriad Genetics to advance comprehensive genomic profiling.

Key findings of the global digital genome market:

  • There is an increasing demand for personalized medicines.
  • The growing awareness in the developing economies contributes to market growth.
  • Advancements in next-generation sequencing (NGS) benefits market growth.

 

Frequently Asked Questions (FAQs):

The global chronic disease burden is expected to reach 57% by 2020. This trend is most likely to affect the emerging countries, as population growth is anticipated to be most significant in developing areas. The increasing prevalence of chronic diseases leads to a rise in the digital genome's use to treat such conditions.
The approval of personalized medicines for disease treatments using the patient's genetic info is anticipated to offer targeted treatment, and is expected to offer lucrative opportunities in the digital genome market.
Sequencing chips is the fastest-growing product in the digital genome market.
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
      2. ADVANCEMENTS IN TECHNOLOGY
      3. SURGING PREVALENCE OF CHRONIC DISEASES
    2. KEY RESTRAINTS
      1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
      2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY
  4. KEY ANALYTICS
    1. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRY
      2. THREAT OF SUBSTITUTION
      3. BUYER’S POWER
      4. SUPPLIER’S POWER
      5. COMPETITIVE RIVALRY
    2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
    3. OPPORTUNITY MATRIX
    4. VENDOR LANDSCAPE
    5. KEY INVESTMENT INSIGHTS
  5. MARKET BY PRODUCT
    1. SEQUENCING AND ANALYZER INSTRUMENTS
    2. DNA/RNA ANALYSIS
    3. SEQUENCING AND ANALYSIS SOFTWARE
    4. SEQUENCING CHIPS
    5. SAMPLE PREP INSTRUMENTS
  6. MARKET BY APPLICATION
    1. DIAGNOSTICS
    2. DRUG DISCOVERY
    3. ACADEMIC RESEARCH
    4. PERSONALIZED MEDICINE
    5. AGRICULTURAL
    6. OTHER APPLICATIONS
  7. MARKET BY END-USER
    1. DIAGNOSTICS AND FORENSIC LABS
    2. ACADEMIC RESEARCH INSTITUTES
    3. HOSPITALS
    4. OTHER END-USERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. THE UNITED STATES
        2. CANADA
      6. EUROPE
        1. MARKET SIZE & ESTIMATES
        2. KEY GROWTH ENABLERS
        3. KEY CHALLENGE
        4. KEY PLAYERS
        5. COUNTRY ANALYSIS
          1. GERMANY
          2. FRANCE
          3. THE UNITED KINGDOM
          4. ITALY
          5. RUSSIA
          6. BELGIUM
          7. POLAND
          8. REST OF EUROPE
        6. ASIA PACIFIC
          1. MARKET SIZE & ESTIMATES
          2. KEY GROWTH ENABLERS
          3. KEY CHALLENGE
          4. KEY PLAYERS
          5. COUNTRY ANALYSIS
            1. CHINA
            2. JAPAN
            3. AUSTRALIA & NEW ZEALAND
            4. INDIA
            5. SOUTH KOREA
            6. THAILAND
            7. INDONESIA
            8. VIETNAM
            9. REST OF ASIA PACIFIC
          6. REST OF WORLD
            1. MARKET SIZE & ESTIMATES
            2. KEY GROWTH ENABLERS
            3. KEY CHALLENGE
            4. KEY PLAYERS
            5. REGIONAL ANALYSIS
              1. LATIN AMERICA
              2. MIDDLE EAST & AFRICA
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGER & ACQUISITIONS
      2. PRODUCT LAUNCH & DEVELOPMENTS
      3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    2. COMPANY PROFILE
      1. ABBOTT LABORATORIES
      2. AGILENT TECHNOLOGIES INC
      3. BECTON, DICKINSON AND COMPANY (BD)
      4. BIOMERIEUX SA
      5. BIO-RAD LABORATORIES INC
      6. HOFFMANN-LA ROCHE
      7. ILLUMINA INC
      8. INSCRIPTA
      9. OXFORD NANOPORE TECHNOLOGIES LTD
      10. PACIFIC BIOSCIENCE
      11. PERKINELMER INC
      12. QIAGEN NV
      13. REGENERON PHARMACEUTICALS
      14. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME

TABLE 2: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL SEQUENCING AND ANALYZER INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL SEQUENCING AND ANALYZER INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL DNA/RNA ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL DNA/RNA ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL SEQUENCING AND ANALYSIS SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL SEQUENCING AND ANALYSIS SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL SEQUENCING CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL SEQUENCING CHIPS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL SAMPLE PREP INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL SAMPLE PREP INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL ACADEMIC RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL ACADEMIC RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL AGRICULTURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL AGRICULTURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL DIAGNOSTICS AND FORENSIC LABS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL DIAGNOSTICS AND FORENSIC LABS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL DIGITAL GENOME MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL DIGITAL GENOME MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: LEADING PLAYERS OPERATING IN NORTH AMERICA DIGITAL GENOME MARKET

TABLE 43: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 44: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 45: LEADING PLAYERS OPERATING IN EUROPE DIGITAL GENOME MARKET

TABLE 46: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: LEADING PLAYERS OPERATING IN ASIA PACIFIC DIGITAL GENOME MARKET

TABLE 49: REST OF WORLD DIGITAL GENOME MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 50: REST OF WORLD DIGITAL GENOME MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 51: LEADING PLAYERS OPERATING IN REST OF WORLD DIGITAL GENOME MARKET

LIST OF FIGURES

FIGURE 1: CHRONIC CONDITIONS IN PATIENTS HOSPITALIZED WITH COVID-19 IN THE UNITED STATES

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, IN 2020

FIGURE 7: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, IN 2020

FIGURE 13: GLOBAL DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL DIGITAL GENOME MARKET, BY END-USER, IN 2020

FIGURE 20: GLOBAL DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 25: UNITED STATES DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: CANADA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: EUROPE DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 28: GERMANY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: FRANCE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: UNITED KINGDOM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: ITALY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: RUSSIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: BELGIUM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: POLAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: REST OF EUROPE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: ASIA PACIFIC DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 37: CHINA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: JAPAN DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: INDIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: SOUTH KOREA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: THAILAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: INDONESIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: VIETNAM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: REST OF ASIA PACIFIC DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: REST OF WORLD DIGITAL GENOME MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 47: LATIN AMERICA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: MIDDLE EAST & AFRICA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample